Salipro has entered into a multi-target collaboration agreement with a global Top 5 pharmaceutical company in the USA.
This partnership leverages Salipro Biotech’s expertise and proprietary technology (Salipro®) to stabilise challenging drug targets including GPCRs, ion channels and transporters, making them accessible for the development of next-generation therapeutics.
Stay tuned for more updates as we continue to push the boundaries of drug discovery!